FARROW JEFFREY S (See Remarks) sold 20.2% of their position (14.40K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $877.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2026ACC: 0001405253-26-000013
Officer· See Remarks
Since Mar 2026
-14.40K
Net shares
Net seller
$877.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
27.88K acquired · 42.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.88K
Price / share
—
Trade value
—
% of position
64.4%
6/15/2026
43.32K→71.20K
Common Stock
Direct
Shares
−14.40K
Price / share
$60.95
Trade value
$877.44K
% of position
20.2%
6/16/2026
71.20K→56.80K
Total
Net shares
+13.48K
Net value
-$877.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | M · Option Exercise | +27.88K | — | — | 64.4% | 43.32K | 71.20K |
| Common Stock Direct | 6/16/2026 | S · Sale | −14.40K | $60.95 | $877.44K | 20.2% | 71.20K | 56.80K |
| Total | +13.48K | -$877.44K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
27.88K shares
Shares
−27.88K
Strike price
Held after
27.88K
Exercisable
—
6/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock27.88K shares | 6/15/2026 | M · Option Exercise | −27.88K | — | 27.88K |